Clinical Operations: Managing Research Grant Requests
Based on a survey of eight leading pharmaceutical organizations, this 15-slide presentation examines how pharmaceutical companies manage unsolicited research grant requests from investigators. Key topic areas in this study include: research request channels, research approval processes, tracking research completion and milestone requirements for payment. Companies can use this information to evaluate their process for managing unsolicited research grant requests.
The study found that companies' research request approval process have varying levels of complexity. For example, some organizations have designated committees and processes for ranking and evaluating requests, while others operate under an ad-hoc or less-complex approval system.
Companies use an average of two separate requirements to track research completion: abstract reviews and research reports. Additionally, 75% require some sort of collateral or research milestone before payment.
This information was collected from Best Practices, LLC Internet Benchmarking Exchange service.
Business Operations > Research and Development > Communications
Industries Profiled:
Biotech; Pharmaceutical; Chemical
Companies Profiled:
Amgen; Almirall; Solvay America; TTY Biopharm; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; Millenium
Special Offer: If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call J.B. Barrow at 919-767-9229 if you have any questions.
Other Research in:
Business Operations > Research and Development > Communications
Select items of interest and click the "Add Selected Items to Cart" button below.
|